Ro Review: The Medication Is at Cost, So Judge the Membership
Ro’s medication prices now match what the manufacturers charge directly — dose for dose, on their own published ladders. That removes the usual thing to criticise a telehealth platform for, and leaves exactly one question worth asking.
- $888The membership on the annual plan — and the entire premium over going direct
- MatchesIts cash medication prices, against NovoCare and LillyDirect, dose by dose
- Only oneOf the three platforms we track that publishes a full price by dose
- $74–149The monthly membership range, depending on how far ahead you prepay
The short version
Ro states that its cash-pay medication prices match LillyDirect, NovoCare and TrumpRx. We checked that claim dose by dose against the manufacturers’ own published ladders, and on the doses we could compare it holds.
That is a meaningful change. The standard criticism of buying a GLP-1 through a telehealth platform is that you pay a markup on the drug for the convenience. On Ro’s published prices you do not. What you pay instead is a separate membership, billed monthly, and that membership is the whole of the difference between Ro and buying the same medication direct.
So the question is not “is Ro overcharging for the drug”. It is “is roughly $888 a year a fair price for a prescription, dose adjustments and someone to contact when the side effects start”. That is a real question with a defensible answer either way, and it depends entirely on whether you already have a prescriber.
We checked the match, dose by dose
Ro’s figures are from its own pricing page. The manufacturer figures are the ones we read directly from NovoCare and LillyDirect and publish on our cost comparison. Both were read on the same day.
| Medication and dose | Ro | Direct from manufacturer |
|---|---|---|
| Wegovy tablet, 1.5 mg | $149 | $149 |
| Wegovy tablet, 4 mg | $199 | $199 |
| Wegovy tablet, 9 and 25 mg | $299 | $299 |
| Wegovy pen, 0.25 and 0.5 mg | $199 | $199 |
| Foundayo, 0.8 mg | $149 | $149 |
| Foundayo, 5.5 mg | $199 | $199 |
| Foundayo, 9 mg and above | $299 | $299 |
| Zepbound KwikPen, from | $299 | $299 |
One number on that page to ignore
Ro advertises savings of “up to 88% off the list price”, computed against figures like $1,349 for the Wegovy pill. That list price is real but close to nobody pays it — the manufacturer’s own self-pay price is the relevant comparison, and against that the saving is zero, because the prices are the same. The discount framing is the weakest thing on an otherwise unusually transparent page.
Ro also carries Foundayo, the oral drug approved in 2026, which not every platform lists yet. Two of its strengths are shown at a limited-time reduction that Ro states requires signing up by 31 December 2026 — the same expiry the manufacturer attaches to its own reduced prices, which is consistent with the prices being passed through rather than set by Ro.
The membership, which is the actual product
The first month is $39, and Ro states it is refunded if you turn out not to be eligible for a GLP-1. After that the rate depends on how far ahead you commit.
| Plan | Monthly | Roughly, per year |
|---|---|---|
| 12 months, prepaid | $74 | ~$888 |
| Month to month | $149 | ~$1,788 |
The gap between those two rows is about $900 a year for the same service, which is the single largest controllable cost on this page. Ro says as much itself. The catch is the one attached to any prepayment: you are committing a year’s fee to a treatment that roughly one person in ten stops early because of side effects, on the trial figures for these drugs. Paying monthly costs more; prepaying annually risks more.
What a year actually comes to
Take Foundayo at its maintenance strength: about $3,650 of medication a year, which is the same whether you buy through Ro or direct. Through Ro on the annual plan you add roughly $888 of membership, so about $4,540. The medication is not the variable. The membership is.
What Ro does that its competitors do not
It publishes a price for every dose. That sounds like a low bar until you try to get the same information from anyone else. On our provider comparison we could not compute a twelve-month cost for two of the three platforms we track, because neither publishes what the higher doses cost — and since nobody stays on a starting dose, a starting-dose price is not a price.
Ro also separates the two charges clearly rather than advertising a medication price that turns out to require a mandatory membership nobody mentioned. Both halves are on one page, in the open. We are crediting the disclosure, not the total — the total is still higher than buying direct.
Who this is worth it for
- If you do not have a prescriber for this. The manufacturer pharmacies dispense; they do not prescribe. Somebody has to write the prescription, review whether the drug suits you and adjust it as you go. Ro’s membership buys that, and $888 a year for ongoing clinical contact is not obviously unreasonable.
- If you already have one, it is harder to justify. With a prescription in hand you can buy the identical medication at the identical price directly from the manufacturer and pay no membership at all. In that situation the membership buys a second opinion you are already getting.
- If you have insurance that might cover it, check first. Ro offers a free coverage check, and every manufacturer advertises an insured rate far below any cash price. Cash pricing is the fallback, not the starting point.
Ro’s pricing page is at ro.co/weight-loss/pricing. We link it so you can check our arithmetic against theirs, which is the point of publishing both.
What we could not verify
- What you are actually charged at checkout. Every figure here is Ro’s published price, not a receipt. We have not been through the flow as a paying patient.
- The quality of the clinical care, which is the thing the membership actually buys and the thing a pricing page cannot show. We grade disclosure and cost, not consultations.
- Whether prices hold. This page’s own figures moved materially in under a fortnight — our earlier reading of Ro predates its shift to manufacturer-matched pricing.
- Refund and cancellation terms on a prepaid annual plan, which matter more than usual given how many people stop these drugs early. Ask before prepaying.
Sources and method
- Every Ro figure. Ro’s own weight loss pricing page, read 5 September 2026, including the per-dose prices behind each medication’s expanded price detail rather than only the headline “starting at” figures.
- Every manufacturer figure. Read the same day from NovoCare and LillyDirect and published on our cost comparison. We compared the two sets ourselves rather than accepting Ro’s claim that they match.
- Commercial relationship. At the time of writing we have no affiliate relationship with Ro and earn nothing from this page. If that changes, this line changes with it and the grade will not. Our affiliate disclosure sets out what commission does and does not buy.
- Method. Published prices only, compared against the manufacturers’ published prices, with the arithmetic shown. Where a saving is advertised against a list price nobody pays, we say so. We do not grade clinical quality, because we cannot measure it from the outside.
All providers compared → Cost without insurance → How we source and verify →
Ro pricing read 5 September 2026. Telehealth pricing changes faster than manufacturer pricing; we recheck this page quarterly and whenever Ro announces a change.